Concentra Group Holdings Parent, Inc.

NYSE:CON

Medical - Equipment & Services

Healthcare
$41.98 +0.53%

+$0.15 today

Market cap
$5.31B
Beta
0.82
P/E (TTM)
20.3
EPS (TTM)
$1.41
Dividend yield
0.88%
52W Low $18.55High $28.94

Volume 0.74M

Average 0.90M

CON Common Stock Repurchased

Cash spent buying back the company's own shares.

Concentra Group Holdings Parent, Inc.NYSE: CON

Common Stock Repurchased · Q3 FY2026 · quarter ended Sep 2026

Common stock repurchased turns negative

Q3 FY2026 common stock repurchased was -$34.65M, compared with $0 a year earlier. Trailing-twelve-month common stock repurchased was -$60.6M. Over 3 fiscal years it compounded at -8.3% a year.

Context

  • Common stock repurchased amounted to 1.0% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Common stock repurchased grew in size in 2 of the last 3 fiscal years.

What to watch

Whether quarterly common stock repurchased holds near -$34.65M or moves back toward the trailing-twelve-month quarterly average of -$15.15M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterSep 2026
-$34.65M+216.2% QoQ
Last fiscal yearDec 2025
-$22.42M+45.6% YoY
LTMSep 2026
-$60.6M+293.5% YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+45.6%——
3-year CAGR-8.3%——
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

USD · from the cash flow

Latest · FY2025
(22.42M) USD
Year-over-year change
-45.6%

Common Stock Repurchased vs competitors

How CON compares with its peers on the latest reported figures

  • CON's LTM Sep 2026 common stock repurchased of $60.6M is the 4th largest of the 10 companies compared; the peer median is $0.
  • Its year-over-year change of +293.5% is the 2nd highest of 7, against a peer median of +100.0%.
  • Common stock repurchased amounts to 2.6% of revenue for CON, versus a peer median of 0.0%.
CON Competitors Peer median
Common Stock Repurchased for CON and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HAEHaemonetics CorporationLTM Jun 2026$178.5M +19.0%+32.6%13.2%
PBHPrestige Consumer Healthcare Inc.LTM Jun 2026$121.51M +101.5%+46.2%11.0%
ITGRInteger Holdings CorporationLTM Jul 2026$100.01M +487.6%+157.5%5.4%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$60.6M +293.5%-8.3%2.6%
CPRXCatalyst Pharmaceuticals, Inc.LTM Mar 2026$39.87M —+54.2%6.7%
BHCBausch Health Companies Inc.LTM Jun 2026$0 +100.0%—0.0%
HCMHUTCHMED (China) LimitedLTM Jun 2025$0 +100.0%—0.0%
BEAMBeam Therapeutics Inc.LTM Jun 2026$0 ——0.0%
ADUSAddus HomeCare CorporationLTM Jun 2026$0 ——0.0%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$0 +100.0%—0.0%
Peer median (excluding CON) $0+100.0%+50.2%0.0%

Competitors are the stored peer set for CON. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income216.04M172.24M184.74M171.9M172.8M
Depreciation & Amortization82.21M73.67M73.05M67.18M75.82M
Deferred Income Tax(1.33M)(8.64M)(6.29M)(2.4M)0
Stock-Based Compensation2.14M2.14M651K2.33M0
Change in Working Capital(7.28M)33.92M(18.7M)30.18M7.96M
Accounts Receivables12.52M(5.93M)(10.26M)(1.6M)(11.14M)
Inventory00000
Accounts Payables00024.59M17.97M
Other Working Capital(19.8M)39.85M(8.44M)7.18M1.13M
Other Non-Cash Items(1.14M)1.01M857K5.5M22.82M
Operating Cash Flow290.64M274.34M234.32M274.68M279.4M
Capital Expenditures(46.79M)(45.98M)(69.34M)(64.33M)(82.34M)
Acquisitions (Net)(20.1M)(11.81M)(6M)(6.97M)0
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities5.09M38K36K27K(414.86M)
Investing Cash Flow(61.8M)(57.75M)(75.31M)(71.27M)(414.86M)
Debt Repayment(326.89M)(184.68M)(161.69M)999.95M90.39M
Common Stock Issued10.13M3.34M3.34M511.2M0
Common Stock Repurchased0(29.05M)(5.32M)(15.4M)(22.42M)
Dividends Paid00(6.13M)(1.54B)(32.08M)
Other Financing Activities(25.82M)534K4.52M(3.63M)(3.78M)
Financing Cash Flow(342.59M)(209.86M)(165.29M)(51.53M)32.1M
Effect of Forex Changes00000
Net Change in Cash(113.75M)6.73M(6.28M)151.88M(103.36M)
Free Cash Flow243.85M228.35M164.98M210.35M197.06M

Concentra Group Holdings Parent, Inc.

NYSE:CON

Intrinsic Alpha fair value

Locked

Current Price

$41.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.